Company intelligence / Profile preview

Indigo BioSystems

Indianapolis, Indiana, USA

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Indigo BioSystems provides automated data analysis and laboratory information management solutions specifically designed for clinical laboratories using mass spectrometry. The company's flagship platform, ASCENT, automates the review of complex analytical data, significantly reducing the time and human error associated with manual data processing in toxicology, endocrinology, and clinical chemistry. By streamlining workflows and ensuring high-quality results, Indigo BioSystems enables laboratories to increase throughput and maintain rigorous compliance standards. In 2022, the company was acquired by LabVantage Solutions to integrate its advanced analytics into a broader laboratory information management system (LIMS) portfolio.

Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Indigo BioSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indigo BioSystems.

Explore the full profile